ReachRxResearch
Home
Research
Sign Up
The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committee
Back to Research Hub
  1. Home
  2. Research Hub
  3. The role of palliative and supportive ca…

The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committee

Bone Marrow Transplantation·October 26Open Access
HematologyPractice changingGraft-Versus-Host DiseaseHaematologic MalignanciesClinical Practice GuidelineCAR-T Cell TherapyHaematopoietic Cell TransplantationPalliative CareMixed

Summary

View source

What was studied

This EBMT guideline paper examined how and when to integrate palliative and supportive care across the full continuum of haematopoietic cell transplantation (HCT) and cellular therapies (including CAR-T), covering adults and children with haematologic malignancies.

Key findings

An international multidisciplinary expert panel generated consensus-based, non-graded recommendations supporting early, systematic palliative care integration to reduce symptom burden, improve quality of life, and facilitate complex decision-making across key domains: symptom management, psychological distress, GvHD, relapse, end-of-life care, advance care planning, caregiver support, health inequities, and clinician wellbeing.

Study limitations

Recommendations are expert-consensus based and non-graded, reflecting heterogeneous and often limited primary evidence; implementation strategies were not empirically tested, and equity-related recommendations acknowledge that access to palliative care remains uneven across health systems.

Clinical implications

Palliative and supportive care should be integrated early and systematically—not reserved for end of life—in all patients undergoing HCT or CAR-T therapy. Use practical referral triggers and patient-reported outcomes to ensure timely, equitable access throughout treatment.

Caveats

  • All recommendations are expert-consensus based and explicitly non-graded, meaning they are not derived from systematic review or meta-analysis and carry no formal evidence grade
  • Health inequity is highlighted as a recognised gap, but no specific interventions to address disparate access to palliative care are empirically validated in the evidence base
  • The paper covers a very broad scope (adult and paediatric HCT and CAR-T) but does not stratify recommendations by transplant type, conditioning intensity, or specific CAR-T product, limiting direct clinical applicability in some settings

Related Questions

Explore related topics

Early palliative care integration in hematopoietic stem cell transplant outcomesCAR-T cell therapy symptom management and quality of lifeAdvance care planning and end-of-life decision-making in hematologic malignancies

Publication Details

Year
2026
Journal
Bone Marrow Transplantation
Source
View article
Keep scrolling
More content below.
Up Next